Leerink Swann Starts Questcor Pharmaceuticals (QCOR) at Outperform; Expecting Meaningful Acthar Growth
Tweet Send to a Friend
Leerink Swann initiates coverage on Questcor Pharmaceuticals (NASDAQ: QCOR) with an Outperform. PT range $50-$53.
Analyst, Irene Lau, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Irene Lau, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
